Bactiguard Holding AB
STO:BACTI B
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| SE |
|
Bactiguard Holding AB
STO:BACTI B
|
476.5m SEK |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.6T JPY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
60.2B USD |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.8B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
105.4B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.1B USD |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.3B CNY |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
875.3B JPY |
Loading...
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD |
Loading...
|
Market Distribution
| Min | -5 565 412.8% |
| 30th Percentile | -5.3% |
| Median | 3% |
| 70th Percentile | 7.5% |
| Max | 12 228% |
Other Profitability Ratios
Bactiguard Holding AB
Glance View
Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm and currently employs 188 full-time employees. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Bactiguard Holding AB is -3.4%, which is above its 3-year median of -20.6%.
Over the last 3 years, Bactiguard Holding AB’s Net Margin has increased from -20.9% to -3.4%. During this period, it reached a low of -62% on Dec 31, 2023 and a high of -3.4% on Jan 1, 2026.
